References:
- Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del
Giacco S, Gajdanowicz P, Gracia IE, Klimek L, Lauerma A, Ollert M,
O’Mahony L, Schwarze J, Shamji MH, Skypala I, Palomares O, Pfaar O,
Torres MJ, Bernstein JA, Cruz AA, Durham SR, Galli SJ, Gómez RM,
Guttman-Yassky E, Haahtela T, Holgate ST, Izuhara K, Kabashima K,
Larenas-Linnemann DE, von Mutius E, Nadeau KC, Pawankar R,
Platts-Mills TAE, Sicherer SH, Park HS, Vieths S, Wong G, Zhang L,
Bilò MB, Akdis CA. Nomenclature of allergic diseases and
hypersensitivity reactions: Adapted to modern needs: An EAACI position
paper. Allergy. 2023 Oct 10.
- Pichler W.J. Delayed Drug Hypersensitivity Reactions. Annals Int
Med 2003;139:683-693
- Pichler WJ. Immune pathomechanism and classification of drug
hypersensitivity. Allergy. 2019 Aug;74(8):1457-1471.
- Han J, Pan C, Tang X, Li Q, Zhu Y, Zhang Y, Liang A.
Hypersensitivity reactions to small molecule drugs. Front Immunol.
2022 Nov 10;13:1016730
- Pichler WJ, Thoo L, Yerly D. Drug Hypersensitivity and
Eosinophilia: The Decisive Role of p-i Stimulation, Allergy 2023, Jul
3.,
- Pichler WJ, Hausmann O. Classification of Drug Hypersensitivity
into Allergic, p-i, and Pseudo-Allergic Forms. Int Arch Allergy
Immunol. 2016;171(3-4):166-179.